| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity
|
Sánchez-Palomino, Sonsoles
|
|
2011
|
29 |
32 |
p. 5250-5259
10 p.
|
article
|
| 2 |
A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen
|
Xiao, Sa
|
|
2011
|
29 |
32 |
p. 5294-5303
10 p.
|
article
|
| 3 |
Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A
|
Matyas, Gary R.
|
|
2011
|
29 |
32 |
p. 5137-5144
8 p.
|
article
|
| 4 |
A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years
|
Schwarz, T.F.
|
|
2011
|
29 |
32 |
p. 5195-5202
8 p.
|
article
|
| 5 |
Archaeosomes with encapsulated antigens for oral vaccine delivery
|
Li, Zhengrong
|
|
2011
|
29 |
32 |
p. 5260-5266
7 p.
|
article
|
| 6 |
Barriers to implementation of the new targeted BCG vaccination in France: A cross sectional study
|
Rossignol, L.
|
|
2011
|
29 |
32 |
p. 5232-5237
6 p.
|
article
|
| 7 |
Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
|
Ebensen, Thomas
|
|
2011
|
29 |
32 |
p. 5210-5220
11 p.
|
article
|
| 8 |
Bovine Neonatal Pancytopenia: Is this alloimmune syndrome caused by vaccine-induced alloreactive antibodies?
|
Bastian, Max
|
|
2011
|
29 |
32 |
p. 5267-5275
9 p.
|
article
|
| 9 |
Characterization of the RepliVax platform for replication-defective flavivirus vaccines
|
Rumyantsev, Alexander A.
|
|
2011
|
29 |
32 |
p. 5184-5194
11 p.
|
article
|
| 10 |
Difficulties in the prevention of cervical cancer: Adults’ attitudes towards HPV vaccination 3 years after introducing the vaccine in Hungary
|
Marek, Erika
|
|
2011
|
29 |
32 |
p. 5122-5129
8 p.
|
article
|
| 11 |
Economic burden of HPV-related cancers in France
|
Borget, I.
|
|
2011
|
29 |
32 |
p. 5245-5249
5 p.
|
article
|
| 12 |
Editorial Board
|
|
|
2011
|
29 |
32 |
p. CO2-
1 p.
|
article
|
| 13 |
Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: Assessment of prevalence and vaccination coverage
|
Melo, Laura Valdiane Luz
|
|
2011
|
29 |
32 |
p. 5290-5293
4 p.
|
article
|
| 14 |
High burden of tick-borne encephalitis in Slovenia—Challenge for vaccination policy
|
Grgič-Vitek, Marta
|
|
2011
|
29 |
32 |
p. 5178-5183
6 p.
|
article
|
| 15 |
HPV vaccination among a community sample of young adult women
|
Manhart, Lisa E.
|
|
2011
|
29 |
32 |
p. 5238-5244
7 p.
|
article
|
| 16 |
HPV vaccine information-seeking behaviors among US physicians: Government, media, or colleagues?
|
Bynum, Shalanda A.
|
|
2011
|
29 |
32 |
p. 5090-5093
4 p.
|
article
|
| 17 |
Human papillomavirus (HPV) vaccination: Perception and practice among French general practitioners in the year since licensing
|
Lutringer-Magnin, D.
|
|
2011
|
29 |
32 |
p. 5322-5328
7 p.
|
article
|
| 18 |
Improvement of H5N1 influenza vaccine viruses: Influence of internal gene segments of avian and human origin on production and hemagglutinin content
|
Abt, Marion
|
|
2011
|
29 |
32 |
p. 5153-5162
10 p.
|
article
|
| 19 |
Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine
|
Carmichael, Jennifer R.
|
|
2011
|
29 |
32 |
p. 5276-5283
8 p.
|
article
|
| 20 |
In memory of Dr. Hitoshi Kamiya
|
Ihara, Toshiaki
|
|
2011
|
29 |
32 |
p. 5329-5330
2 p.
|
article
|
| 21 |
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
|
Barouch, Dan H.
|
|
2011
|
29 |
32 |
p. 5203-5209
7 p.
|
article
|
| 22 |
Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine
|
Velasquez, Lissette S.
|
|
2011
|
29 |
32 |
p. 5221-5231
11 p.
|
article
|
| 23 |
Methodologic reporting requirements for clinical trials: Advancing the science today and tomorrow
|
Poland, Gregory A.
|
|
2011
|
29 |
32 |
p. 5087-5089
3 p.
|
article
|
| 24 |
Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: Revisiting the role of host innate susceptibility and routes of challenge
|
Simon, Raphael
|
|
2011
|
29 |
32 |
p. 5094-5106
13 p.
|
article
|
| 25 |
Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity
|
Henderson, Angela
|
|
2011
|
29 |
32 |
p. 5304-5312
9 p.
|
article
|
| 26 |
Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine
|
Kuo, Chen-Yen
|
|
2011
|
29 |
32 |
p. 5171-5177
7 p.
|
article
|
| 27 |
Persistence of antibodies in 4–8 year old Austrian children after vaccination with hexavalent DTaP–HBV–IPV/Hib and MMR vaccines
|
Paulke-Korinek, Maria
|
|
2011
|
29 |
32 |
p. 5130-5136
7 p.
|
article
|
| 28 |
Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule
|
Wiertsema, Selma P.
|
|
2011
|
29 |
32 |
p. 5163-5170
8 p.
|
article
|
| 29 |
Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: Towards an in vitro assay for vaccine immunogenicity
|
Hoefnagel, Marcel H.N.
|
|
2011
|
29 |
32 |
p. 5114-5121
8 p.
|
article
|
| 30 |
Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
|
Turley, Christine B.
|
|
2011
|
29 |
32 |
p. 5145-5152
8 p.
|
article
|
| 31 |
Socioeconomic status, demographics, beliefs and A(H1N1) vaccine uptake in the United States
|
Galarce, Ezequiel M.
|
|
2011
|
29 |
32 |
p. 5284-5289
6 p.
|
article
|
| 32 |
Trivalent influenza vaccine and febrile adverse events in Australia, 2010: Clinical features and potential mechanisms
|
Blyth, C.C.
|
|
2011
|
29 |
32 |
p. 5107-5113
7 p.
|
article
|
| 33 |
Variable epitope libraries: New vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response
|
Charles-Niño, Claudia
|
|
2011
|
29 |
32 |
p. 5313-5321
9 p.
|
article
|
Journal description